Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2024)
Spyre Therapeutics (SYRE) posted Net Equity Issued and Repurchased of -$157.3 million for Q3 2024, down 116425.93% on a QoQ basis from -$135000.0 in Q2 2024.
Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2024) Analysis & Trends
Spyre Therapeutics' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at -$157.3 million for Q3 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$157.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $209.1 million (changed N/A YoY) and the FY2023 annual result came in at $197.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$157.3 million for Q3 2024 at Spyre Therapeutics, down from -$135000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $197.4 million in Q4 2023 and bottomed at -$157.3 million in Q3 2024.
- A 3-year average of $46.7 million and a median of $24.6 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -157.31 Mn |
| Sep 30, 2024 | -157.31 Mn |
| Jun 30, 2024 | -135,000.00 |
| Jun 30, 2024 | -135,000.00 |
| Mar 31, 2024 | 169.21 Mn |
| Mar 31, 2024 | 169.21 Mn |
| Dec 31, 2023 | 197.36 Mn |
| Dec 31, 2023 | 197.36 Mn |
| Dec 31, 2020 | 24.60 Mn |
| Dec 31, 2020 | 24.60 Mn |
| Mar 31, 2017 | 96,000.00 |
| Mar 31, 2017 | 96,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Mar 31, 2015 | 43.68 Mn |
| Mar 31, 2015 | 43.68 Mn |